01 1CAPSULE (IMMED./COMP. RELEASE)
02 1CAPSULE, COATED, SOFT GELATIN
03 1CAPSULE, DELAYED RELEASE
04 1CAPSULE, ENTERIC COATED PELLETS
05 1CAPSULE, EXTENDED RELEASE
06 1CAPSULE, HARD GELATIN
07 1CAPSULE, SUSTAINED ACTION
08 1GRANULE
09 1GRANULE, FOR RECONSTITUTION
10 1INJECTABLE
11 1POWDER, FOR INHALATION
12 2POWDER, FOR INJECTION SOLUTION
13 2POWDER, FOR INJECTION SOLUTION, LYOPHILIZED
14 1POWDER, FOR ORAL SUSPENSION
15 6TABLET
16 1TABLET (IMMED./COMP. RELEASE), COATED
17 1TABLET (IMMED./COMP. RELEASE), FILM COATED
18 1TABLET (IMMED./COMP. RELEASE), UNCOATED, BUCCAL
19 2TABLET (IMMED./COMP. RELEASE), UNCOATED, CHEWABLE
20 3TABLET, COATED
21 1TABLET, DELAYED ACTION
22 1TABLET, DELAYED ACTION, ENTERIC COATED
23 1TABLET, DELAYED RELEASE
24 1TABLET, EXTENDED RELEASE
25 1TABLET, FILM COATED
26 1TABLET, FILM COATED, EXTENDED RELEASE
27 1TABLET, ORALLY DISINTEGRATING
28 1TABLET, SUSTAINED ACTION
29 1TABLET, SUSTAINED ACTION, COATED
30 1TABLET, SUSTAINED ACTION, FILM COATED
01 11.16
02 32.5
03 14.75
04 115.69
05 123.75
06 125
07 128.75
08 140
09 146.06
10 148
11 153.8
12 258
13 171.91
14 172.12
15 175.69
16 179.34
17 190
18 193.3
19 198.7
20 1108
21 1117
22 1128
23 1130.7
24 1144.19
25 1157.95
26 1177.25
27 1180.9
28 1204
29 1232.05
30 1238.24
31 1300.8
32 1333
33 1433
34 1453.6
35 1468.7
36 1605
37 1735.2
ANHYDROUS LACTOSE
Route : BUCCAL
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 23.75
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : IM - IV
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 2.5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : IM - IV
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 2.5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : INTRACAVITARY
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 4.75
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : INTRAVENOUS
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 28.75
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : IV(INFUSION)
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 2.5
Potency Unit : %
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 46.06
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 71.91
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 40
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
ANHYDROUS LACTOSE
Route : ORAL
CAS : 63423
UNII : 3SY5LH9PMK
Potency Amount : 117
Potency Unit : MG
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
LOOKING FOR A SUPPLIER?